These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35419810)

  • 1. Prediction of new organ onset in recurrent immunoglobulin G4-related disease during 10 years of follow-up.
    Liu Z; Peng Y; Li J; Lu H; Peng L; Zhou J; Zhou S; Huang C; Wang M; Zhu L; Chen H; Wang L; Fei Y; Zhao Y; Zeng X; Zhang W
    J Intern Med; 2022 Jul; 292(1):91-102. PubMed ID: 35419810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and therapeutic response of immunoglobulin G4-related disease: a retrospective study of 127 Chinese patients.
    An W; Wu Z; Li M; Yu H; Zhao X; Wang X; Wang Y; Wang Q; Duan W; Kong Y; Ma H; Ou X; You H; Liu Y; Li P; Duan T; Jia J
    Orphanet J Rare Dis; 2022 Aug; 17(1):307. PubMed ID: 35927746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and relapse risks factors of IgG4 related disease: a single-center retrospective study.
    Zhang X; Zeng Z; Tian H; Wang N; Wang Y; Tong J; Chang B; Jin X; Huang D; Wang Y; Cui H; Guan L; Li Y
    Clin Exp Med; 2023 Nov; 23(7):3527-3538. PubMed ID: 37392248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients.
    Wang L; Zhang P; Zhang X; Lin W; Tang H; Li J; Wang M; Liu X; Fei Y; Chen H; Peng L; Zhang L; Lai Y; Zeng X; Li X; Xue H; Zhao Y; Zhang F; Zhang W
    Rheumatology (Oxford); 2019 May; 58(5):820-830. PubMed ID: 30561747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revealing the distinct clinical patterns and relapse risk factors in seronegative IgG4-RD patients: A retrospective cohort study over a decade.
    Peng Y; Wang M; Sun R; Nie Y; Zhang N; He X; Sun B; Peng L; Fei Y; Zhou J; Li M; Zhang W
    J Intern Med; 2024 Aug; 296(2):200-212. PubMed ID: 38924246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and predictive relapse factors of IgG4-related disease following treatment: a long-term cohort study.
    Peng Y; Li JQ; Zhang PP; Zhang X; Peng LY; Chen H; Zhou JX; Zhang SZ; Yang HX; Liu JJ; Guo HF; Li J; Zhang X; Zhao Y; Zeng XF; Zhang FC; Fei YY; Zhang W
    J Intern Med; 2019 Nov; 286(5):542-552. PubMed ID: 31121062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IgE in the clinical features and disease outcomes of IgG4-related disease: a large retrospective cohort study.
    Zhou J; Peng Y; Peng L; Wu D; Li J; Jiang N; Li J; Lu H; Liu Z; Luo X; Teng F; Fei Y; Zhang W; Zhao Y; Zeng X
    Arthritis Res Ther; 2020 Oct; 22(1):255. PubMed ID: 33097076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different factors underlie recurrent and de novo organ involvement in immunoglobulin G4-related disease.
    Mizushima I; Tsuge S; Fujisawa Y; Hara S; Suzuki F; Ito K; Fujii H; Yamada K; Kawano M
    Rheumatology (Oxford); 2020 Mar; 59(3):513-518. PubMed ID: 31373632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse.
    Lanzillotta M; Della-Torre E; Milani R; Bozzolo E; Bozzalla-Cassione E; Rovati L; Arcidiacono PG; Partelli S; Falconi M; Ciceri F; Dagna L
    Arthritis Res Ther; 2018 Oct; 20(1):222. PubMed ID: 30285841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical characteristics of 346 patients with IgG
    Zhang PP; Zhao JZ; Wang M; Feng RE; Liu XW; Lai XM; Li XJ; Zeng JG; Shi HJ; Zhu HD; Xue W; Zhang H; Chen YY; Fei LY; Peng XF; Zeng FC; Zhang YM; Zhang W
    Zhonghua Nei Ke Za Zhi; 2017 Sep; 56(9):644-649. PubMed ID: 28870031
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients.
    Wang L; Zhang P; Wang M; Feng R; Lai Y; Peng L; Fei Y; Zhang X; Zhao Y; Zeng X; Zhang F; Zhang W
    Arthritis Res Ther; 2018 Apr; 20(1):65. PubMed ID: 29636109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study.
    Peng L; Lu H; Zhou J; Zhang P; Li J; Liu Z; Wu D; Zhang S; Yang Y; Bai W; Wang L; Fei Y; Zhang W; Zhao Y; Zeng X; Zhang F
    Arthritis Res Ther; 2021 Apr; 23(1):102. PubMed ID: 33827676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum IgG4 level during initial treatment as a predictor of relapse in IgG4-related disease.
    Choi SJ; Ahn SM; Oh JS; Hong S; Lee CK; Yoo B; Kim YG
    PLoS One; 2023; 18(3):e0282852. PubMed ID: 36893163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort.
    Liu Y; Zeng Q; Zhu L; Gao J; Wang Z; Wang Z; Yang F; Wang K; Chen D; Xia C; Zhang S; Wang Y; Shen D; Yu G; Li ZG
    Rheumatology (Oxford); 2020 Aug; 59(8):2115-2123. PubMed ID: 32097488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations, clinical course, and outcomes of immunoglobulin G4-related disease.
    Phaopraphat K; Ngamjanyaporn P; Narongroeknawin P; Kasitanon N; Katchamart W
    Int J Rheum Dis; 2020 Nov; 23(11):1468-1473. PubMed ID: 32808722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and relapse risks of IgG4-related ophthalmic disease: a single-center experience in China.
    Zhao Z; Mou D; Wang Z; Zeng Q; Wang Z; Xue J; Ren L; Liu Y; Su Y
    Arthritis Res Ther; 2021 Mar; 23(1):98. PubMed ID: 33789746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial.
    Peng L; Nie Y; Zhou J; Wu L; Chen X; Wang F; Li J; Peng Y; Lu H; Zhao L; Li M; Zhao Y; Zeng X; Fei Y; Zhang W
    Ann Rheum Dis; 2024 Apr; 83(5):651-660. PubMed ID: 38216319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical features and outcomes of proliferative, fibrotic, and mixed subtypes of IgG4-related disease: A retrospective cohort study.
    Peng L; Zhang X; Zhou J; Li J; Liu Z; Lu H; Peng Y; Fei Y; Zhao Y; Zeng X; Zhang W
    Chin Med J (Engl); 2024 Feb; 137(3):303-311. PubMed ID: 37538048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe asthma as the initial clinical manifestation of IgG4-related disease: a retrospective clinical study.
    Liu X; Shao C; Yu C; Huang H; Pan R; Xu K; Zhang X; Xu Z
    BMC Pulm Med; 2022 Apr; 22(1):141. PubMed ID: 35413899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of immunoglobulin G4-related sialadenitis: outcomes of glucocorticoid therapy combined with steroid-sparing agents.
    Hong X; Zhang YY; Li W; Liu YY; Wang Z; Chen Y; Gao Y; Sun ZP; Peng X; Su JZ; Cai ZG; Zhang L; He J; Ren LM; Yang HY; Li ZG; Yu GY
    Arthritis Res Ther; 2018 Jan; 20(1):12. PubMed ID: 29382364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.